Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Statistics

Total Valuation

DNLI has a market cap or net worth of $2.14 billion. The enterprise value is $1.13 billion.

Market Cap	2.14B
Enterprise Value	1.13B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025, before market open.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

DNLI has 145.28 million shares outstanding. The number of shares has increased by 20.87% in one year.

Current Share Class	145.28M
Shares Outstanding	145.28M
Shares Change (YoY)	+20.87%
Shares Change (QoQ)	+0.67%
Owned by Insiders (%)	5.20%
Owned by Institutions (%)	92.54%
Float	130.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	47.54
PB Ratio	1.90
P/TBV Ratio	1.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.56, with a Debt / Equity ratio of 0.05.

Current Ratio	9.56
Quick Ratio	8.92
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,030.41

Financial Efficiency

Return on equity (ROE) is -35.21% and return on invested capital (ROIC) is -24.03%.

Return on Equity (ROE)	-35.21%
Return on Assets (ROA)	-22.58%
Return on Invested Capital (ROIC)	-24.03%
Return on Capital Employed (ROCE)	-43.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.08M
Employee Count	422
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DNLI has paid $68,000 in taxes.

Income Tax	68,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.72% in the last 52 weeks. The beta is 1.33, so DNLI's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-32.72%
50-Day Moving Average	13.98
200-Day Moving Average	21.18
Relative Strength Index (RSI)	55.74
Average Volume (20 Days)	1,475,423

Short Selling Information

The latest short interest is 12.10 million, so 8.33% of the outstanding shares have been sold short.

Short Interest	12.10M
Short Previous Month	11.74M
Short % of Shares Out	8.33%
Short % of Float	9.27%
Short Ratio (days to cover)	8.83

Income Statement

Revenue	n/a
Gross Profit	-395.24M
Operating Income	-515.21M
Pretax Income	-419.62M
Net Income	-453.94M
EBITDA	-513.95M
EBIT	-515.21M
Earnings Per Share (EPS)	-$2.67

Balance Sheet

The company has $817.93 million in cash and $51.57 million in debt, giving a net cash position of $1.00 billion or $6.90 per share.

Cash & Cash Equivalents	817.93M
Total Debt	51.57M
Net Cash	1.00B
Net Cash Per Share	$6.90
Equity (Book Value)	1.12B
Book Value Per Share	7.73
Working Capital	786.76M

Cash Flow

In the last 12 months, operating cash flow was -$365.54 million and capital expenditures -$18.84 million, giving a free cash flow of -$384.38 million.

Operating Cash Flow	-365.54M
Capital Expenditures	-18.84M
Free Cash Flow	-384.38M
FCF Per Share	-$2.65

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DNLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.87%
Shareholder Yield	-20.87%
Earnings Yield	-21.26%
FCF Yield	-18.00%

Analyst Forecast

The average price target for DNLI is $33.85, which is 130.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.85
Price Target Difference	130.27%
Analyst Consensus	Strong Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1